Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint BlockadeClin. Cancer Res 2022 Sep 15;28(18)4121-4130, P Johannet, W Liu, D Fenyo, M Wind-Rotolo, M Krogsgaard, JM Mehnert, JS Weber, J Zhong, I Osman
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.